BRPI0718307A2 - Uso de oligossacarídeos indigeríveis, composição nutricional, oligossacarídeos indigeríveis, e, método para melhora de resistência à insulina, prevenção da queda glicêmica pós-prandial e/ou diminuição da resposta à glicose pós-prandial de uma refeição - Google Patents
Uso de oligossacarídeos indigeríveis, composição nutricional, oligossacarídeos indigeríveis, e, método para melhora de resistência à insulina, prevenção da queda glicêmica pós-prandial e/ou diminuição da resposta à glicose pós-prandial de uma refeiçãoInfo
- Publication number
- BRPI0718307A2 BRPI0718307A2 BRPI0718307-0A2A BRPI0718307A BRPI0718307A2 BR PI0718307 A2 BRPI0718307 A2 BR PI0718307A2 BR PI0718307 A BRPI0718307 A BR PI0718307A BR PI0718307 A2 BRPI0718307 A2 BR PI0718307A2
- Authority
- BR
- Brazil
- Prior art keywords
- response
- indigestible oligosaccharides
- glandose
- prevention
- post
- Prior art date
Links
- 229920001542 oligosaccharide Polymers 0.000 title 2
- 150000002482 oligosaccharides Chemical class 0.000 title 2
- 206010022489 Insulin Resistance Diseases 0.000 title 1
- 230000002641 glycemic effect Effects 0.000 title 1
- 235000016709 nutrition Nutrition 0.000 title 1
- 230000000291 postprandial effect Effects 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Pediatric Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/NL2006/050275 WO2008054193A1 (en) | 2006-11-02 | 2006-11-02 | Nutritional products that comprise saccharide oligomers |
| NLPCT/NL2006/050275 | 2006-11-02 | ||
| PCT/NL2007/050530 WO2008054211A1 (en) | 2006-11-02 | 2007-11-02 | Nutritional products comprising saccharide oligomers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BRPI0718307A2 true BRPI0718307A2 (pt) | 2014-04-29 |
| BRPI0718307B1 BRPI0718307B1 (pt) | 2020-11-17 |
Family
ID=38134585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0718307-0A BRPI0718307B1 (pt) | 2006-11-02 | 2007-11-02 | uso de oligossacarídeos indigeríveis e composições nutricionais |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US8637487B2 (pt) |
| EP (1) | EP2086353B1 (pt) |
| JP (1) | JP2010515665A (pt) |
| CN (1) | CN101626696B (pt) |
| AU (1) | AU2007314732A1 (pt) |
| BR (1) | BRPI0718307B1 (pt) |
| CA (1) | CA2668312C (pt) |
| DK (1) | DK2086353T3 (pt) |
| ES (1) | ES2714575T3 (pt) |
| HU (1) | HUE042644T2 (pt) |
| IL (1) | IL198517A0 (pt) |
| MX (1) | MX2009004814A (pt) |
| PL (1) | PL2086353T3 (pt) |
| RU (1) | RU2469557C2 (pt) |
| TR (1) | TR201903494T4 (pt) |
| WO (2) | WO2008054193A1 (pt) |
| ZA (1) | ZA200903497B (pt) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006012536A2 (en) | 2004-07-22 | 2006-02-02 | Ritter Andrew J | Methods and compositions for treating lactose intolerance |
| US8791065B2 (en) | 2009-01-19 | 2014-07-29 | Nutri Co., Ltd. | Low-concentration nutritional composition |
| ES2600960T3 (es) | 2009-02-24 | 2017-02-13 | Ritter Pharmaceuticals, Inc. | Formulaciones prebióticas y procedimientos de uso |
| WO2010104374A1 (en) | 2009-03-09 | 2010-09-16 | N.V. Nutricia | Nutritional composition inducing a postprandial endocrine response |
| JP6077303B2 (ja) | 2009-05-07 | 2017-02-08 | タト エ リル アングルディアント フランス ソシエテ パ アクシオンス シンプリフィエ | アルファ−(1,2)−分岐アルファ−(1,6)オリゴデキストランを含有する組成物及びアルファ−(1,2)−分岐アルファ−(1,6)オリゴデキストランの製造方法 |
| IT1399244B1 (it) * | 2009-07-31 | 2013-04-11 | Pharmarte S R L | Formulazione di barretta specifica per la gravidanza. |
| US8617636B2 (en) * | 2009-10-01 | 2013-12-31 | Roquette Freres | Carbohydrate compositions having a greater impact on the insulinemic response than on the glycemic response, their preparation and their uses |
| WO2011137249A1 (en) | 2010-04-28 | 2011-11-03 | Ritter Pharmaceuticals, Inc. | Prebiotic formulations and methods of use |
| DE102011012494A1 (de) * | 2011-02-25 | 2012-08-30 | Humana Milchunion Eg | Prebiotische Kohlenhydrat-Zusammensetzungen |
| GB2492559B (en) * | 2011-07-05 | 2018-07-25 | Clasado Inc | Composition and method for preventing or reducing the risk of developing a syndrome |
| PH12014500453A1 (en) * | 2011-10-18 | 2020-12-18 | SociaTa Des Produits Nestla S A | Composition for use in increasing insulin sensitivity and/or reducing insulin resistance |
| JP5927663B2 (ja) * | 2011-10-21 | 2016-06-01 | 松谷化学工業株式会社 | 血糖値の上昇が緩やかな糖質組成物及び飲食品 |
| CA2975091A1 (en) * | 2015-01-26 | 2016-08-04 | Cadena Bio, Inc. | Oligosaccharide compositions for use as food ingredients and methods of producing thereof |
| JP6722697B2 (ja) | 2015-01-26 | 2020-07-15 | カデナ・バイオ・インコーポレイテッド | 動物飼料として使用するためのオリゴ糖組成物及びその生成方法 |
| US10190142B2 (en) * | 2016-01-25 | 2019-01-29 | King-Prebiotics Biotechnology (Tw) Co., Ltd. | High-purity galactooligosaccharide compositions, preparations, and applications thereof |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2097041C1 (ru) * | 1994-11-22 | 1997-11-27 | Чепурной Иван Петрович | Способ лечения сахарного диабета |
| EP1310173B2 (en) * | 1997-06-23 | 2014-12-31 | Société des Produits Nestlé S.A. | Composition for providing nutrition to diabetics |
| ATE270822T1 (de) * | 1999-05-20 | 2004-07-15 | Nestle Sa | Verfahren zur erhöhung der propionateproduktion im gastrointestinaltrakt |
| DE19961182B4 (de) | 1999-12-18 | 2006-01-12 | Südzucker AG Mannheim/Ochsenfurt | Galactomannan-Oligosaccharide und Verfahren zu deren Herstellung sowie deren Verwendung |
| US6774111B1 (en) * | 2000-03-14 | 2004-08-10 | Abbott Laboratories | Carbohydrate system and a method for providing nutrition to a diabetic |
| FI109602B (fi) * | 2001-01-25 | 2002-09-13 | Valio Oy | Probioottiyhdistelmä |
| JP2002306131A (ja) | 2001-04-16 | 2002-10-22 | Takara Bio Inc | 食品、飲料又は飼料 |
| CN1164186C (zh) * | 2001-04-29 | 2004-09-01 | 上海光明乳业股份有限公司 | 益菌奶及其制造方法 |
| DE60210604T3 (de) * | 2001-05-31 | 2013-12-24 | Abbott Laboratories | Polymer-kontrolliertes induziertes viskoses ballaststoffsystem und dessen verwendungen |
| US6989166B2 (en) * | 2001-12-20 | 2006-01-24 | N.V. Nutricia | Soft drink replacer |
| EP1332759B1 (en) * | 2002-02-04 | 2005-09-28 | Kyowa Hakko Kogyo Co., Ltd. | Pharmaceutical and nutritional compositions containing a di- or oligosaccharide as insulin secretion promoter |
| JP4401659B2 (ja) * | 2002-02-04 | 2010-01-20 | 協和発酵バイオ株式会社 | インスリン分泌促進剤 |
| JP4328490B2 (ja) * | 2002-03-01 | 2009-09-09 | 天野エンザイム株式会社 | 飲食品の風味改善剤及びこれが添加された食品並びに飲食品の風味改善方法 |
| CN100528169C (zh) * | 2002-05-31 | 2009-08-19 | 天野酶株式会社 | 抗炎剂、变应性疾病预防剂或改善剂及功能性食品 |
| FR2844453B1 (fr) | 2002-09-13 | 2006-05-19 | Agronomique Inst Nat Rech | Utilisation de pre-biotiques pour la prevention de l'installation du diabete de type ii |
| JP2004149471A (ja) | 2002-10-31 | 2004-05-27 | Shiratori Pharmaceutical Co Ltd | 血糖低下剤 |
| EP2033529B1 (en) * | 2003-10-24 | 2019-12-11 | N.V. Nutricia | Synbiotic composition for infants |
| CN1545937A (zh) * | 2003-12-03 | 2004-11-17 | 上海交大昂立股份有限公司 | 一种含有益生元的儿童保健食品及其制备方法 |
| JP2008506771A (ja) | 2004-07-19 | 2008-03-06 | エヌ.ブイ.・ヌートリシア | 血糖値を調節するためのアスパルテートを使用するための調製物 |
| DK1629850T4 (da) * | 2004-08-24 | 2013-07-01 | Nutricia Nv | Næringssammensætning indeholdende ufordøjelige oligosaccharider |
| CN1332619C (zh) * | 2004-09-20 | 2007-08-22 | 段治义 | 魔芋低聚糖快速减肥食品及其制作方法 |
| EP1656839A1 (en) * | 2004-11-11 | 2006-05-17 | N.V. Nutricia | Nutrition containing lipid blend |
| WO2006108008A2 (en) * | 2005-04-06 | 2006-10-12 | Novartis Ag | A method and composition for nutritionally improving glucose control and insulin action |
-
2006
- 2006-11-02 WO PCT/NL2006/050275 patent/WO2008054193A1/en not_active Ceased
-
2007
- 2007-11-02 DK DK07834660.8T patent/DK2086353T3/en active
- 2007-11-02 ES ES07834660T patent/ES2714575T3/es active Active
- 2007-11-02 WO PCT/NL2007/050530 patent/WO2008054211A1/en not_active Ceased
- 2007-11-02 EP EP07834660.8A patent/EP2086353B1/en active Active
- 2007-11-02 RU RU2009120697/10A patent/RU2469557C2/ru not_active IP Right Cessation
- 2007-11-02 PL PL07834660T patent/PL2086353T3/pl unknown
- 2007-11-02 MX MX2009004814A patent/MX2009004814A/es active IP Right Grant
- 2007-11-02 TR TR2019/03494T patent/TR201903494T4/tr unknown
- 2007-11-02 AU AU2007314732A patent/AU2007314732A1/en not_active Abandoned
- 2007-11-02 CN CN200780045179.0A patent/CN101626696B/zh active Active
- 2007-11-02 JP JP2009536179A patent/JP2010515665A/ja active Pending
- 2007-11-02 HU HUE07834660A patent/HUE042644T2/hu unknown
- 2007-11-02 BR BRPI0718307-0A patent/BRPI0718307B1/pt active IP Right Grant
- 2007-11-02 CA CA2668312A patent/CA2668312C/en not_active Expired - Fee Related
- 2007-11-02 US US12/513,330 patent/US8637487B2/en not_active Expired - Fee Related
-
2009
- 2009-05-03 IL IL198517A patent/IL198517A0/en unknown
- 2009-05-20 ZA ZA200903497A patent/ZA200903497B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008054193A1 (en) | 2008-05-08 |
| PL2086353T3 (pl) | 2019-05-31 |
| US20100069327A1 (en) | 2010-03-18 |
| ES2714575T3 (es) | 2019-05-29 |
| HUE042644T2 (hu) | 2019-07-29 |
| MX2009004814A (es) | 2009-07-17 |
| CN101626696A (zh) | 2010-01-13 |
| CA2668312C (en) | 2015-08-25 |
| DK2086353T3 (en) | 2019-03-25 |
| EP2086353A1 (en) | 2009-08-12 |
| RU2469557C2 (ru) | 2012-12-20 |
| RU2009120697A (ru) | 2010-12-10 |
| WO2008054211A9 (en) | 2008-10-16 |
| AU2007314732A1 (en) | 2008-05-08 |
| TR201903494T4 (tr) | 2019-04-22 |
| BRPI0718307B1 (pt) | 2020-11-17 |
| CA2668312A1 (en) | 2008-05-08 |
| CN101626696B (zh) | 2016-01-20 |
| US8637487B2 (en) | 2014-01-28 |
| EP2086353B1 (en) | 2018-12-12 |
| IL198517A0 (en) | 2010-02-17 |
| JP2010515665A (ja) | 2010-05-13 |
| ZA200903497B (en) | 2010-05-26 |
| WO2008054211A1 (en) | 2008-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0718307A2 (pt) | Uso de oligossacarídeos indigeríveis, composição nutricional, oligossacarídeos indigeríveis, e, método para melhora de resistência à insulina, prevenção da queda glicêmica pós-prandial e/ou diminuição da resposta à glicose pós-prandial de uma refeição | |
| PT2550972T (pt) | Anticorpo agonista de klotho-beta para utilização no tratamento de diabetes mellitus ou resistência à insulina | |
| BRPI0911681A2 (pt) | composto, composição farmacêutica, e, método para ativar a via de proteína quinase ativada por 5'-amp em uma célula | |
| BRPI0816097A2 (pt) | composição farmacêutica, método para tratar eritema em um paciente com rosácea, e, uso de uma composição. | |
| BRPI0816133A2 (pt) | Composição que emite flavorizante, dispositivo que emite flavorizante, tablete comprimido ou moldado, produto alimentício acondicionado, e, métodos para fabricar um dispositivo que emite flavorizante e uma composição que emite flavorizante. | |
| IL203915A (en) | Annotations of 2-Benzylphenyl-6-Hydroxymethyl-Tetrahydro-2 H-Pyrene-3,4,5-Triol | |
| EP1980203B8 (en) | Blood sensor and blood test apparatus having the same | |
| HUE052428T2 (hu) | Készítmény és eljárás acetaldehid gyomorban való megkötésére | |
| DK2835059T3 (da) | Flydende, enteral ernæringssammensætning med højt proteinindhold | |
| IL197831A (en) | Human antibodies that bind 4cxcr, preparations containing them and their uses | |
| BRPI0918139A2 (pt) | composição, alimento medicinal ou funcional, suplemento alimentar ou dietético para tratamento de distúrbios de desenvolvimento pervasivos com terapêuticos redox-ativos e uso | |
| BRPI0916576A2 (pt) | pelo menos uma entidade química, composição farmacêutica, e, método para tratar uma condição ou distúrbio. | |
| WO2009051706A3 (en) | Peptide compounds for treating obesity and insulin resistance | |
| WO2007112069A3 (en) | Endothelin and endothelin receptor agonists in the treatment of metabolic diseases | |
| BRPI0922233A2 (pt) | compostos, composições farmacêiticas e métodos para uso no tratamento de síndromes metabólicas. | |
| BRPI0720604A2 (pt) | Composição e método para detecção de desmineralização | |
| IL196965A (en) | Analogues of (r, r) or (s, r) phenoterol, their pharmaceutical composition containing them and their use for the treatment of heart failure | |
| BRPI0719250A2 (pt) | Métodos e composições com opalescência reduzida. | |
| EP2103653A4 (en) | COMPOSITION AND COMPOSITION COMPREHENSIVE LIGHT-EMITTING ITEM | |
| BRPI0719272A2 (pt) | Composição de enzima, e, método para preparar uma composição de enzima. | |
| EP1927603A4 (en) | COMPOSITION OF SYRUP, RESIN MORTAR COMPOSITION AND METHOD OF APPLICATION | |
| WO2008022169A8 (en) | Controlled flow polymer blends and products including the same | |
| BRPI0819930A2 (pt) | composto, éster de pró-droga, composição farmacêutica, e, métodos para tratar uma doença ou condição mediada por sglt e para tratar diabetes | |
| PL2128253T3 (pl) | Przeciwciało anty-FGF23 i kompozycja zawierająca takie przeciwciało | |
| EP2119367A4 (en) | OIL AND FAT COMPOSITION AND FOOD OR DRINK CONTAINING THE OIL AND FAT COMPOSITION |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B15K | Others concerning applications: alteration of classification |
Free format text: PROCEDIMENTO AUTOMATICO DE RECLASSIFICACAO. AS CLASSIFICACOES IPC ANTERIORES ERAM: A23L 1/29; A61P 3/10. Ipc: A23L 33/21 (2016.01), A23L 33/10 (2016.01), A23L 3 Ipc: A23L 33/21 (2016.01), A23L 33/10 (2016.01), A23L 3 |
|
| B15K | Others concerning applications: alteration of classification |
Ipc: A23L 33/21 (2016.01), A23L 33/10 (2016.01), A23L 3 |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 17/11/2020, OBSERVADAS AS CONDICOES LEGAIS. |